Navigation Links
OpenQ Secures Investment from Leading Mid-Atlantic Venture Firm
Date:9/10/2009

Grotech Ventures Backs Innovative Information, Research and Technology Platform for Life Sciences Marketing, R&D and Medical Affairs

Charlottesville, VA, San Diego, CA, New York, NY and Paris, France (PRWeb) -- OpenQ, the industry leader in innovative tools for information and research for life sciences marketing, compliance, R&D and medical affairs announces that it has secured an equity investment from Grotech Ventures. The new capital will fuel an expansion of openQ into new markets and new research areas.

"We are thrilled to receive an investment and strategic guidance from a fund like Grotech, who has a track record of enabling technology, information and services for life sciences companies to grow and meet their full potential," stated Jim Zuffoletti, openQ President. "My co-founder, Otavio Freire, and I look forward to our continued partnership in securing openQ's position as a leader in its sector providing technology, information and research to life sciences companies around the world."

"Grotech is pleased to begin a collaboration with openQ to help the company extend their current leadership position as an innovator in life sciences technology and information. We are impressed with openQ's rapid growth and successful track record serving the largest pharmaceutical and the smallest biotechs with creative solutions to help ensure compliance, speed time to approval, and accelerate adoption," added Chuck Cullen, General Partner at Grotech.

The openQ Platfom

The openQ platform includes breakthrough tools and research to identify trends, organizations and key individuals who impact adoption and scientific dialogue while ensuring compliance. The company's easy to use technology provides instant access to vital market information updated in real time. The openQ platform includes the following on-demand information and software tools:

 
  • openIdentify - the only real time KOL identification solution for marketing, medical affairs and R&D, backed by over 500 million records of dynamically updated information
  • openPresenter - the only slide management solution to ensure complete online and offline speaker compliance
  • openProfile - the leading information solution to support competitive intelligence and medical and marketing program planning
  • openKOL - for marketing teams to successfully engage KOLs
  • openMSL - the leading solution for managing field medical organizations
  • openSpeaker - for Speaker selection and speaker bureau management
  • openIIT - for IIT compliance, submission and approval workflow

About openQ

In its sixth year of rapid growth, openQ has offices throughout the United States, Asia, and Europe and a growing client list that spans the globe. The continued interest of life science companies in openQ's products has led them to expand their client base fourfold since 2006. The company serves eight of the top ten pharmaceutical companies and three of the top five medical device companies. For more information, visit www.openq.com.

About Grotech Ventures


Founded in 1984, Grotech Ventures is a leading early investor in high-potential technology companies. Grotech seeks investments in communications and IT infrastructure, software and services, and Internet and digital media. The firm focuses on the Mid-Atlantic and Southeast regions and other select geographies. Grotech continues to invest and add value throughout the growth of its portfolio companies. The firm has a strong combination of financial backing, industry relationships, and deep domain and operational expertise to accelerate growth. With over $1 billion under management in its seven funds, Grotech supports early-stage companies through investments starting at $500,000. For further information, visit www.grotech.com.

###

Read the full story at http://www.prweb.com/releases/openq/venture-investment/prweb2851684.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. OpenQ Posts a 200% Revenue Growth in the First Half of 2009
2. OpenQ is Awarded Prestigious Life Sciences Industry Award
3. Cappella Inc. Secures $17.3 Million Series C Investment
4. SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Germany & Austria
5. Sinobiopharma Secures Rights to Seven Key Patents
6. Aerovance Secures $38 Million in Equity Financing
7. VIA Pharmaceuticals Secures Financing Up to $10.0 Million
8. Pearl Therapeutics Secures $8 Million in Debt Financing
9. Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets
10. Sopherion Therapeutics Secures $55 Million in Series C Funding
11. Northwest Biotherapeutics Secures $700,000 Equity Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... 23, 2016 Andrew ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the ... Convention Center and will showcase its product’s latest features from June 26 to ... a scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity ... intelligent tools designed, tuned and optimized exclusively for Okuma CNC machining centers at ... result of a collaboration among several companies with expertise in toolholding, cutting tools, ...
Breaking Biology Technology:
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
(Date:4/26/2016)... and LONDON , April ... part of EdgeVerve Systems, a product subsidiary of ... today announced a partnership to integrate the Onegini ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... their customers enhanced security to access and transact ...
(Date:4/19/2016)... The new GEZE SecuLogic access ... "all-in-one" system solution for all door components. It can ... door interface with integration authorization management system, and thus ... minimal dimensions of the access control and the optimum ... offer considerable freedom of design with regard to the ...
Breaking Biology News(10 mins):